XML 28 R16.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Share-based compensation | 9 Months Ended
--- | ---
Sep. 30, 2022
Share-Based Payment Arrangements [Abstract] |
Share-based compensation | Share-based compensationThe Company has five components of its share-based compensation plan: stock options, deferred share units (“DSUs”), restricted share units (“RSUs”), performance share units (“PSUs”) and employee share purchase plan (“ESPP”). Share-based compensation expense for the three and nine months ended September 30, 2022 was $1,000 and $3,624, respectively (2021 - $745 and $1,662). The expense associated with each component is as follows:
| Three months ended September 30, |  | Nine months ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
| $ |  | $ |  | $ |  | $
Stock options | 607 |  |  | 443 |  |  | 1,655 |  |  | 1,103 |
DSUs | 233 |  |  | 231 |  |  | 632 |  |  | 488 |
RSUs | 124 |  |  | — |  |  | 1,225 |  |  | — |
ESPP | 36 |  |  | 71 |  |  | 112 |  |  | 71 |
| 1,000 |  |  | 745 |  |  | 3,624 |  |  | 1,662 |
There were no PSUs issued and outstanding for the three and nine months ended September 30, 2022 and 2021. The changes in the number of stock options during the nine months ended September 30, 2022 and 2021 were as follows:
| 2022 |  | 2021 1
| Number of options |  | Weighted average exercise price |  | Number of options |  | Weighted average exercise price
| # |  | C$ |  | # |  | C$
Options outstanding – January 1 | 1,283,088 |  |  | 12.00 |  |  | 1,516,641 |  |  | 6.73 |
Options granted 1 | 168,588 |  |  | 44.91 |  |  | 115,969 |  |  | 53.19 |
Options forfeited | (63,415) |  |  | 46.41 |  |  | (28,736) |  |  | 14.84 |
Options exercised | (9,179) |  |  | 14.52 |  |  | (147,025) |  |  | 3.37 |
Options outstanding – September 30 | 1,379,082 |  |  | 14.42 |  |  | 1,456,849 |  |  | 10.61 |
Options exercisable – September 30 | 887,779 |  |  | 4.06 |  |  | 814,367 |  |  | 2.54 |
1 In March 2021, the Company granted stock options to certain executives. Subsequently, the Company identified an error in determining the expected life and volatility inputs used in the Black-Scholes pricing model to calculate the fair value of options, which led to the Company determining that 63,992 excess options were granted in March 2021 to six senior executives (the “Awardees”). The granting of excess options was immaterial to the Company but the error resulted in an award of options to the Awardees that was not reasonable and appropriate to grant. During 2021, the Company amended and restated the option award agreements for those affected Awardees to reflect the issuance of the appropriate number of options. The following table is a summary of the Company’s stock options outstanding as at September 30, 2022:
Options outstanding |  | Options exercisable
Exercise price range |  | Number outstanding |  | Weighted average remaining contractual life (years) |  | Exercise price range |  | Number exercisable
C$ |  | # |  | # |  | C$ |  | #
0.0001 - 1.09 |  | 784,368 |  |  | 4.71 |  | 0.0001 - 1.09 |  | 748,368 |
8.86 - 11.06 |  | 51,811 |  |  | 8.20 |  | 8.86 - 11.06 |  | 21,084 |
15.79 - 16.00 |  | 268,499 |  |  | 7.03 |  | 15.79 - 16.00 |  | 95,969 |
26.43 - 95.12 |  | 274,404 |  |  | 9.26 |  | 26.43 - 95.12 |  | 22,358 |
|  | 1,379,082 |  |  | 6.19 |  |  |  | 887,779 |
The following table is a summary of the Company’s stock options outstanding as at September 30, 2021:
Options outstanding |  | Options exercisable
Exercise price range |  | Number outstanding |  | Weighted average remaining contractual life (years) |  | Exercise price range |  | Number exercisable
C$ |  | # |  | # |  | C$ |  | #
0.0001 - 1.09 |  | 784,368 |  |  | 5.70 |  | 0.0001 - 1.09 |  | 695,968 |
8.86 - 11.06 |  | 190,522 |  |  | 9.21 |  | 8.86 - 11.06 |  | 59,784 |
15.79 - 16.00 |  | 341,701 |  |  | 8.03 |  | 15.79 - 16.00 |  | 57,529 |
26.43 - 69.48 |  | 140,258 |  |  | 9.45 |  | 26.43 - 69.48 |  | 1,086 |
|  | 1,456,849 |  |  | 7.17 |  |  |  | 814,367 |
DSUs The following table presents information concerning the number of DSUs granted by the Company:
| #
DSUs – December 31, 2021 | 59,654 |
Granted (at C$38.97 - $86.93 per unit) | 25,372 |
DSUs - September 30, 2022 | 85,026 |
RSUs The following table presents information concerning the number of RSUs granted by the Company:
| #
RSUs – December 31, 2021 | 46,591 |
Granted (at C$40.30 - $54.26 per unit) | 97,816 |
Released (at C$94.05 per unit) | (2,800) |
Forfeited (at C$86.38 - $94.05 per unit) | (30,222) |
RSUs - September 30, 2022 | 111,385 |

X
- Definition Share-Based Payment Arrangements [Abstract] + References No definition available. + Details
Name: | docebo_ShareBasedPaymentArrangementsAbstract
Namespace Prefix: | docebo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for share-based payment arrangements. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 44 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_44&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration